British AI drug discovery firm BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. His ...

California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of ...

Gan & Lee Pharmaceuticals (SHE: 603087) reported positive Phase II trial results for its diabetes drugs GZR18, GZR4, and ...

RNA specialist Wave Life Sciences has been told by Takeda that the Japanese drugmaker is to bring to an end the last facet of ...

Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma ...

Shares of US protein-based vaccine maker Novavax closed down 19.4% at $10.15 yesterday having dropped as much as 24%, on the ...

The rocky road goes on for Intercept Pharmaceuticals with its primary biliary cholangitis (PBC) candidate Ocaliva ...

The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM) is set to grow from $11.5 billion in ...

A new NIH clinical trial shows the Jynneos (MVA-BN) vaccine is safe for adolescents and produces an antibody response similar ...

The US Food and Drug Administration (FDA) yesterday published the guidance for industry, “Requests for Reconsideration at the ...

Sanofi has partnered with Orano Med, a subsidiary of Orano Group, to develop radioligand therapies for rare cancers. Sanofi ...